Henrik Vissing
- Molecular Biology top 5%
- Genetics top 2%
- Oncology top 10%
- Cancer Research top 5%
- Immunology and Allergy top 2%
- Co-authors
- Niels TommerupHans‐Jürgen ThiesenWolfram MeyerJudith MargolinF. J. RauscherJoshua R. FriedmanFrancesco RamirezJim Holloway
- Topics
- Connective tissue disorders research (9 papers)Pancreatic function and diabetes (9 papers)Diabetes and associated disorders (5 papers)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Henrik Vissing
46 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 2.0k
- Genetics 906
- Oncology 419
- Cancer Research 331
- Immunology and Allergy 219
Countries citing papers authored by Henrik Vissing
This map shows the geographic impact of Henrik Vissing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Vissing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Vissing more than expected).
Fields of papers citing papers by Henrik Vissing
This network shows the impact of papers produced by Henrik Vissing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Vissing. The network helps show where Henrik Vissing may publish in the future.
Co-authorship network of co-authors of Henrik Vissing
This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Vissing. A scholar is included among the top collaborators of Henrik Vissing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Vissing. Henrik Vissing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 41 | |
| 3 | 49 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 56 | |
| 7 | BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppressionbreakdown → | 569 |
| 8 | 36 | |
| 9 | 83 | |
| 10 | 135 | |
| 11 | 114 | |
| 12 | 7 | |
| 13 | 10 | |
| 14 | 5 | |
| 15 | 9 | |
| 16 | 27 | |
| 17 | 2 | |
| 18 | 5 | |
| 19 | 2 | |
| 20 | 9 |
About Henrik Vissing
Henrik Vissing is a scholar working on Genetics, Immunology and Allergy and Endocrinology, Diabetes and Metabolism, having authored 48 papers that have together received 2.8k indexed citations. Recurring topics across this work include Connective tissue disorders research (9 papers), Pancreatic function and diabetes (9 papers) and Diabetes and associated disorders (5 papers). The work is most often cited by research in Immunology and Allergy (219 citations), Genetics (906 citations) and Molecular Biology (2.0k citations). Henrik Vissing has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Niels Tommerup, Hans‐Jürgen Thiesen, Wolfram Meyer, Judith Margolin, F. J. Rauscher, Joshua R. Friedman, Francesco Ramirez, Jim Holloway, David Heard and Peder Lisby Nørby. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.